Stanford Health Care Diabetes Education and Prevention Program was recently recognized by the American Diabetes Association as a national Diabetes Education program.
The program utilizes a patient-centered comprehensive diabetes education and prevention outreach program for individuals with pre-diabetes and diabetes. Staff members are all certified diabetes educators. Program services include individual and group consultations that cover the critical facets of diabetes self-management including blood glucose monitoring, meal planning, physical activity guidelines, current medications, complication prevention strategies, goal setting and integration of the latest in diabetes related research, technologies and devices.
This comprehensive program is integrated throughout the Stanford Health Care system to assure comprehensive accessibility and coordination with the individuals interdisciplinary team.
The program is integrated into 21 Bay Area Primary Care and Endocrine Clinics and three corporate partners - Yahoo, Cisco, QUALCOMM (San Diego). SHC assures the necessary staff training and materials for these sites that are compliant with the national ADA guidelines.
The Stanford Diabetes Research Center (SDRC) announced that it has received a major program grant from the National Institutes of Health (NIH). Stanford is only one of a handful of U.S. institutions to be supported as a NIH ‘Diabetes Research Center’. This is the first time Stanford has garnered this prestigious center designation
The SDRC is comprised of over 90 distinguished members from multiple schools at Stanford, including faculty in the Schools of Medicine, Engineering, and Arts and Sciences. These members are united by a common interest in understanding, treating and curing diabetes, including type 1 and type 2 diabetes, and forms of diabetes linked to pancreatic cancer. To support this work, the SDRC provides Research Cores, a Pilot and Feasibility Grant Program, Enrichment Activities, and other functions to support diabetes-related research at Stanford. The SDRC leadership includes its Director, Dr. Seung Kim, Professor of Developmental Biology and, by courtesy, of Medicine (Endocrinology and Oncology Divisions), and the SDRC Associate Director, Dr. David Maahs, Professor of Pediatrics, and Chief of the Division of Pediatric Endocrinology.
“Stanford has a superb group of investigators dedicated to transformative diabetes research, whose efforts are coordinated and aligned by the SDRC,” stated Kim. “We are thrilled to have earned this important support from the NIH to foster the SDRC programs. We also view this as important recognition of the outstanding and enduring fundamental and clinical investigations at Stanford that focus on understanding and treating diabetes and its complications. Unfortunately, diabetes incidence in its major forms is increasing worldwide. So this support is timely.”
The program project (P30) award for 7.7 million dollars from the NIDDK will provide support over the next five years for key functions of the SDRC.
On October 3rd, the SDRC hosted a reception to celebrate this distinction. The reception was attended by SDRC members and School of Medicine leadership, including Dean Minor and Dr. Harry Greenberg.
The NIH-funded T32 Training Program in Diabetes, Endocrinology and Metabolism at Stanford, directed by Dr. Andrew Hoffman, was renewed for another 5 years in July 2017, allowing continuous training now in its 42nd year. However, the program is the lineal descendant of a prior Training Program that existed for 20 years, so the Endocrine training program at Stanford is actually 62 years old. Although primarily based in the Division of Endocrinology, Gerontology and Metabolism of the Department of Medicine, the Training Program has always encompassed the broad scope of endocrine research training by incorporating members of other clinical and basic science departments, fostering improved collaborations and interactions among the investigators from these multiple departments with a focus on endocrinology.
The Stanford psychiatrist, neuroscientist and bioengineer will be honored for three distinct contributions to the medical field: optogenetics, hydrogel-tissue chemistry and research into depression. Read more here.